Who is sponsoring NCT05087082?

NCT05087082 is sponsored by Nordsjaellands Hospital.

What drugs are being tested in NCT05087082?

Interventions in NCT05087082: Virtual Hospital at Home - Home admission of epidemic patients.

What condition does NCT05087082 study?

NCT05087082 studies Telemedicine, Epidemic Disease.

Is NCT05087082 still recruiting?

NCT05087082 is currently completed. Last updated 28 September 2023.

Last reviewed 2023-09-28 · How we verify

NCT05087082: Influenz-er

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Early Transfer of Hospitalized Patients Incl. COVID-19 to a Virtual Hospital at Home Model - a Clinical Feasibility Study

Completed NA Last updated 28 September 2023

What this trial tests

NA trial testing Virtual Hospital at Home - Home admission of epidemic patients in Telemedicine in 19 participants. Completed in 20 September 2023.

Timeline

20 April 2022

Primary endpoint
20 September 2023

20 September 2023

Quick facts

Lead sponsor	Nordsjaellands Hospital
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	health services research
Enrollment	19
Start date	20 April 2022
Primary completion	20 September 2023
Estimated completion	20 September 2023
Sites	1 location across Denmark

Drugs / interventions tested

Virtual Hospital at Home - Home admission of epidemic patients

Conditions studied

Telemedicine — all drugs for Telemedicine →
Epidemic Disease — all drugs for Epidemic Disease →

Sponsor

Nordsjaellands Hospital

Who can join

18 and older, any sex, with Telemedicine or Epidemic Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will be part of a larger, 'virtual hospital-at-home' (vHaH) project called Influenz-er. vHaH is a care model designed to deliver medical care in the home, as a substitute for a continued inpatient hospital admission. This study will be a clinical feasibility study, which will be used to guide the framing and design of the final telemedicine supported vHaH model for hospitalized patients.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Transforming health care: Investigating Influenzer, a novel telemedicine-supported early discharge program for patients with lower respiratory tract infection: A non-randomized feasibility study.
Sandreva T, Larsen MN, Rasmussen MK, Nielsen TL, et al · · 2025 · cited 7× · PMID 38780386 · DOI 10.1177/1357633x241254572
By the book or beyond? Lessons on implementation fidelity in remote patient monitoring within a hybrid hospital-at-home feasibility study.
Dreisig TS, Larsen M, von Sydow C, Nielsen T, et al · · 2026 · PMID 41708158 · DOI 10.1136/bmjhci-2025-101832

Verify or expand the search:

Other recruiting trials for Telemedicine

Currently open trials in the same condition.

NCT07265037 — Integrated TCM - Western Medicine Strategy for Long - Distance Diabetes Management · NA · recruiting
NCT07042477 — Integrated Telemedicine Program Evaluation · NA · recruiting
NCT07124325 — Remote Cardiotocography Telemonitoring Within High-risk Pregnancy Care · NA · recruiting
NCT06942533 — Effect of Visual Feedback From the SpiroGym Mobile Application · NA · recruiting
NCT06980740 — Video-Tumorboard PLUS · recruiting

Other Nordsjaellands Hospital trials

Trials by the same sponsor.

NCT07167498 — Continuous Remote Vital Sign Monitoring During Labour Analgesia With Remifentanil · not yet recruiting
NCT07237984 — Colorectal Omics and ofCS Proteoglycans (COCO) in Screening and a Diagnostic Pathway · not yet recruiting
NCT06689280 — Physical Rehabilitation of Older Persons Following a Community-Acquired Infection Hospitalization - A Randomised-Control · NA · not yet recruiting
NCT06564857 — Remifentanil Versus Rocuronium for Optimizing Video Laryngoscopy-assisted Tracheal Intubation · Phase 4 · recruiting
NCT07132723 — Associations Between Time to Reduction and Complications in Patients With Dislocated Total Hip Arthroplasty · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05087082 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Nordsjaellands Hospital
Last refreshed: 28 September 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05087082.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing